Commission Implementing Regulation (EU) 2023/1311 of 27 June 2023 granting a Union authorisation for the biocidal product family ‘CVAS Biocidal Product Family based on L (+) Lactic Acid’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
Adopted EU legal act marked as EEA relevant by the EU but considered by the EEA EFTA States not to be relevant for incorporation into the EEA Agreement. There may be a number of reasons for this: the act may fall outside the scope of the EEA Agreement; it may have expired in the EU; or incorporation may not be required due to the contents or nature of the act. For some of the acts, discussions with the EU on their relevance are still ongoing. Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Legal documents
Commission Implementing Regulation (EU) 2023/1311 of 27 June 2023 granting a Union authorisation for the biocidal product family ‘CVAS Biocidal Product Family based on L (+) Lactic Acid’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Durchführungsverordnung (EU) 2023/1311 der Kommission vom 27. Juni 2023 zur Erteilung einer Unionszulassung für die Biozidproduktfamilie „CVAS Biocidal Product Family based on L (+) Lactic Acid“ gemäß der Verordnung (EU) Nr. 528/2012 des Europäischen Parlaments und des Rates
History
27.06.2023
Adoption date in the EU
18.07.2023
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.